venlafaxine hydrochloride has been researched along with medroxyprogesterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stearns, V | 1 |
| Hsiao, MC; Lin, YH; Liu, CY | 1 |
1 review(s) available for venlafaxine hydrochloride and medroxyprogesterone
| Article | Year |
|---|---|
Management of hot flashes in breast cancer survivors and men with prostate cancer.
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthetic; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Male; Medroxyprogesterone; Menopause, Premature; Paroxetine; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
1 other study(ies) available for venlafaxine hydrochloride and medroxyprogesterone
| Article | Year |
|---|---|
Combined antidepressant and hormone treatment is effective for chemotherapy-induced menopausal syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Contraceptives, Oral, Synthetic; Cyclohexanols; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Estrogens; Female; Follicle Stimulating Hormone; Humans; Lymphoma, B-Cell; Medroxyprogesterone; Menopause, Premature; Panic Disorder; Psychiatric Status Rating Scales; Severity of Illness Index; Venlafaxine Hydrochloride | 2005 |